Treatment for glomerulonephritis with 2 - [ 4- ( -7-Ethyl-5H-pyrrolo [ 2,3-b ] - pyrazin6 -yl) propan-2-ol

Details for Australian Patent Application No. 2009322478 (hide)

Owner Sanofi-Aventis

Inventors Oligino, Thomas; Gillespy, Timothy A.; Dharanipragada, Ramalinga; Allen, Elizabeth M.

Agent Watermark

Pub. Number AU-A-2009322478

PCT Pub. Number WO2010/065571

Priority 61/119,476 03.12.08 US

Filing date 2 December 2009

Wipo publication date 10 June 2010

International Classifications

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065571 Priority application(s): WO2010/065571

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322480-Ball piston steering devices and methods of use

2009322474-Methods and compositions for altering health, wellbeing, and lifespan